Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure...
Source: http://www.medicalnewstoday.com/releases/241399.php
LEVEL 3 COMMUNICATIONS, INC. IKON OFFICE SOLUTIONS, INC. NVIDIA CORPORATION CA, INC.
Tidak ada komentar:
Posting Komentar